Showing results (461-470 of 758) with videos related to

Sort By:
Pageof 76
Stem Cell Research & Therapy|June 11, 2021
Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient miceFederica Casiraghi, Pamela Yossenaidy Rodriguez Ordonez, Nadia Azzollini, et al.
Journal of the American Society of Nephrology : JASN|May 12, 2006
Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazoneAriela Benigni, Carla Zoja, Susanna Tomasoni, et al.
Lancet (London, England)|February 28, 2017
Ethical issues in dialysis therapyVivekanand Jha, Dominique E Martin, Joanne M Bargman, et al.
Stem Cell Research|August 2, 2021
Human iPSC-derived neural crest stem cells can produce EPO and induce erythropoiesis in anemic miceValerio Brizi, Sara Buttò, Domenico Cerullo, et al.
Biomedicines|December 24, 2021
Unravelling the Role of PAX2 Mutation in Human Focal Segmental GlomerulosclerosisLorena Longaretti, Piera Trionfini, Valerio Brizi, et al.
The American Journal of Pathology|March 28, 2006
Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective interventionDaniela Macconi, Mauro Abbate, Marina Morigi, et al.
Nature Reviews. Nephrology|December 7, 2018
Estimated GFR: time for a critical appraisalEsteban Porrini, Piero Ruggenenti, Sergio Luis-Lima, et al.
International Journal of Molecular Sciences|November 25, 2023
Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular ProtectionMonica Locatelli, Daniela Rottoli, Rayan Mahmoud, et al.
JCI Insight|August 10, 2018
SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathyPaola Cassis, Monica Locatelli, Domenico Cerullo, et al.
Pageof 76